Free CME/CE Education On-Demand

Explore Our CME/CE On-Demand Lineup

Select a tile below to find out more!

Featured Activities (BiSpecifics)

Bispecific Antibodies: Past, Present, and Future (Through Sep 22, 2026)

This multi-faculty CME course is the first installment in a three-part series offering an in-depth exploration of bispecific antibody therapy.

Mitigation and Management of Bispecific Antibody Toxicities in Myeloma & Lymphoma (Through Sep 22, 2026)

This multi-faculty CME course is the second installment in a three-part series offering an in-depth exploration of bispecific antibody therapy.

Effective Implementation of Bispecific Antibodies (Through Sep 22, 2026)

This multi-faculty CME course is the final installment in a three-part series offering an in-depth exploration of bispecific antibody therapy.

Free CME/CE Oncology

CATEGORY: SOLID TUMOR

Targeting Soft-Tissue Tumors: Advances in the Management of Desmoid Tumors and TGCT (Through June 30, 2026)

Current Approaches to Systemic Management of Regionally Advanced or Metastatic Melanoma (Through Sept 5, 2026) -

Molecular Imaging for Metastatic Breast Cancer (Through Dec 1, 2026) -

Evolving Treatment Landscape in HR+/HER2- Metastatic Breast Cancer: Integrating Biomarkers and Novel Targeted Agents (Through Dec 1, 2026)

Practical Approaches to Identifying and Managing Adverse Events in HR+/HER2- Metastatic Breast Cancer (Through Dec 1, 2026)

Supportive Care in Individuals with Head & Neck Cancer (Through Jan 23, 2027)

Living With Small Cell Lung Cancer (SCLC): Current Therapies and Looking Towards the Future (Through Jan 23, 2027)

Spotlight on Desmoid Tumors: Bridging Knowledge Gaps for Optimal Patient Care (Through Feb 13, 2027)

CATEGORY: HEMATOLOGY

Moving Forward in Multiple Myeloma (Through Sept 5, 2026)

Breaking the Cycle: Evolving Strategies for Pain Management in Sickle Disease (Through Sept 5, 2026)

Mitigation and Management of Bispecific Antibody Toxicities in Myeloma & Lymphoma (Through Sept 22, 2026)

Managing CAR T-cell Related Toxicities: The Acute, The Subacute, and The Chronic (Through Jan 23, 2027)

Closing the Gap: Optimizing AML Treatment in Aging Adults (Through Jan 23, 2027)

CATEGORY: GENERAL CANCER

Identifying and Managing Common Immunotherapy-Related Adverse Events (Through Sept 5, 2026)

Incorporating Occupational Therapy into Cancer Care: Enhancing Independence and Quality of Life (Through Sept 5, 2026)

Optimizing Skeletal Health During Cancer Treatment: Diagnosing Osteoporosis and Preventing Fractures (Through Sept 5, 2026)

Management of Cancer-Associated Thrombosis (CAT) (Through Sept 5, 2026)

Advancing Cancer Therapies: The Role of Phase I Clinical Trials (Through Sept 5, 2026)

Navigating the Complexities of Cellular Therapy: Identifying Risks and Interventions to Minimize Toxicity (Through Sept 5, 2026)

Bispecific Antibodies: Past, Present, and Future (Through Sept 22, 2026)

Effective Implementation of Bispecific Antibodies (Through Sept 22, 2026)

Fe-sponse Ready: Managing IV Iron Infusions with Confidence (Through Jan 23, 2027)

Radiation Oncology: Demystifying The Magic (Through Jan 23, 2027)

Integrative Oncology: A Patient Centered and Multidisciplinary Approach to Cancer Care (A Panel Discussion) (Through Jan 23, 2027)

Fertility Preservation in Cancer Patients (Through Jan 23, 2027)

Beyond the Infusion Chair: Practical Implications of Subcutaneous Immunotherapies (Through Jan 23, 2027)

Navigating Herbal and Supplement Use in Cancer Patients (Through Jan 23, 2027)

Free CME/CE NON ONCOLOGY

Check back soon!